We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OWL icon
801
Blue Owl Capital
OWL
$19B
$9K ﹤0.01%
+546
New +$10.4K
PFN
802
PIMCO Income Strategy Fund II
PFN
$698M
$9K ﹤0.01%
1,200
– –
SGML icon
803
CALL
Sigma Lithium
SGML
$1.28B
$9K ﹤0.01%
1,557
+1,322
+563% +$7.95K
SPRO icon
804
Spero Therapeutics
SPRO
$72.4M
$9K ﹤0.01%
+5,300
New +$11.7K
SSYS icon
805
Stratasys
SSYS
$769M
$9K ﹤0.01%
819
+519
+173% +$5.59K
SARO
806
StandardAero Inc
SARO
$8.99B
$9K ﹤0.01%
342
-14,658
-98% -$411K
WXM
807
WF International Ltd
WXM
$12.8M
$9K ﹤0.01%
+290
New +$9.45K
APTV icon
808
CALL
Aptiv
APTV
$10.1B
$8K ﹤0.01%
+100
New +$7.54K
BFK
809
DELISTED
BlackRock Municipal Income Trust
BFK
$8K ﹤0.01%
800
– –
BLE
810
DELISTED
BlackRock Municipal Income Trust II
BLE
$8K ﹤0.01%
800
– –
CGEM icon
811
Cullinan Oncology
CGEM
$1.26B
$8K ﹤0.01%
+1,365
New +$10K
COPX icon
812
PUT
Global X Copper Miners ETF NEW
COPX
$8B
$8K ﹤0.01%
+150
New +$7.25K
GPRO icon
813
GoPro
GPRO
$113M
$8K ﹤0.01%
+4,095
New +$6.09K
HLF icon
814
Herbalife
HLF
$1.26B
$8K ﹤0.01%
1,024
-2,452
-71% -$23.1K
INBX icon
815
Inhibrx
INBX
$1.46B
$8K ﹤0.01%
250
– –
MRNA icon
816
Moderna
MRNA
$25.5B
$8K ﹤0.01%
341
+307
+903% +$8.56K
NMCO icon
817
Nuveen Municipal Credit Opportunities Fund
NMCO
$585M
$8K ﹤0.01%
800
– –
NVDA icon
818
CALL
NVIDIA
NVDA
$5.46T
$8K ﹤0.01%
47
+33
+236% +$5.75K
NVDA icon
819
PUT
NVIDIA
NVDA
$5.46T
$8K ﹤0.01%
45
+30
+200% +$5.23K
ROG icon
820
Rogers Corp
ROG
$2.5B
$8K ﹤0.01%
100
– –
ECHO
821
CALL
EchoStar
ECHO
$26.6B
$8K ﹤0.01%
+110
New +$4.98K
STIM icon
822
Neuronetics
STIM
$228M
$8K ﹤0.01%
+3,000
New +$10.7K
STRO icon
823
Sutro Biopharma
STRO
$356M
$8K ﹤0.01%
+1,000
New +$8.51K
U icon
824
CALL
Unity
U
$19.6B
$8K ﹤0.01%
210
+110
+110% +$4.08K
XPRO icon
825
Expro Ltd
XPRO
$2.06B
$8K ﹤0.01%
+751
New +$8.15K
31 32
33
34 35

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.